These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35644423)

  • 1. Effect of colchicine on inflammatory markers in patients with coronary artery disease: A meta-analysis of clinical trials.
    Pan Z; Cheng J; Yang W; Chen L; Wang J
    Eur J Pharmacol; 2022 Jul; 927():175068. PubMed ID: 35644423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease.
    Nidorf M; Thompson PL
    Am J Cardiol; 2007 Mar; 99(6):805-7. PubMed ID: 17350370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of the effect of colchicine on C-reactive protein in patients with acute and chronic coronary syndromes.
    Alam M; Kontopantelis E; Mamas MA; Savinova OV; Jhaveri A; Siddiqui E; Jhamnani S
    Coron Artery Dis; 2023 May; 34(3):210-215. PubMed ID: 36762630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high-sensitivity C-reactive protein.
    Fiolet ATL; Silvis MJM; Opstal TSJ; Bax WA; van der Horst FAL; Mosterd A; de Kleijn D; Cornel JH
    PLoS One; 2020; 15(8):e0237665. PubMed ID: 32866166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colchicine effectively attenuates inflammatory biomarker high-sensitivity C-reactive protein (hs-CRP) in patients with non-ST-segment elevation myocardial infarction: a randomised, double-blind, placebo-controlled clinical trial.
    Gholoobi A; Askari VR; Naghedinia H; Ahmadi M; Vakili V; Baradaran Rahimi V
    Inflammopharmacology; 2021 Oct; 29(5):1379-1387. PubMed ID: 34420187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Colchicine in Reducing Inflammatory Biomarkers and Cardiovascular Risk in Coronary Artery Disease: A Meta-analysis of Clinical Trials.
    Sethuramalingam S; Maiti R; Hota D; Srinivasan A
    Am J Ther; 2023 May; 30(3):e197-e208. PubMed ID: 34264887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Resveratrol Supplementation on Inflammatory Markers: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Koushki M; Dashatan NA; Meshkani R
    Clin Ther; 2018 Jul; 40(7):1180-1192.e5. PubMed ID: 30017172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose colchicine and high-sensitivity C-reactive protein after myocardial infarction: A combined analysis using individual patient data from the COLCOT and LoDoCo-MI studies.
    Sun M; Dubé MP; Hennessy T; Schultz CJ; Barhdadi A; Rhainds D; Hillis GS; Tardif JC
    Int J Cardiol; 2022 Sep; 363():20-22. PubMed ID: 35716932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of low-dose colchicine in acute and chronic coronary syndromes: A systematic review and meta-analysis.
    Aimo A; Pascual Figal DA; Bayes-Genis A; Emdin M; Georgiopoulos G
    Eur J Clin Invest; 2021 Apr; 51(4):e13464. PubMed ID: 33251579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability of C-reactive protein levels among patients with stable coronary artery disease and on statin therapy.
    Blum A; Costello R; Samsel L; Zalos G; McCoy P; Csako G; Waclawiw MA; Cannon RO
    Isr Med Assoc J; 2009 Oct; 11(10):602-5. PubMed ID: 20077946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent and joint effects of high-sensitivity c-reactive protein and hypoalbuminemia on long-term all-cause mortality among coronary artery disease: a prospective and multicenter cohort study.
    Huang H; Yu Y; Chen L; Chen S; Tang R; Li Q; Wei W; Bao K; Huang Z; Lai W; Wang B; Tan N; Chen J; Liu J; Liu Y
    BMC Cardiovasc Disord; 2021 Dec; 21(1):613. PubMed ID: 34961476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of colchicine in patients with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials.
    Bytyçi I; Bajraktari G; Penson PE; Henein MY; Banach M; ;
    Br J Clin Pharmacol; 2022 Feb; 88(4):1520-1528. PubMed ID: 34409634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: A LoDoCo2 biomarker substudy.
    Silvis MJM; Fiolet ATL; Opstal TSJ; Dekker M; Suquilanda D; Zivkovic M; Duyvendak M; The SHK; Timmers L; Bax WA; Mosterd A; Cornel JH; de Kleijn DPV
    Atherosclerosis; 2021 Oct; 334():93-100. PubMed ID: 34492522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum interleukin-34 in patients with coronary artery disease.
    Li Z; Jin D; Wu Y; Zhang K; Hu P; Cao X; Chen Z
    J Int Med Res; 2012; 40(5):1866-70. PubMed ID: 23206468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Trials.
    Kofler T; Kurmann R; Lehnick D; Cioffi GM; Chandran S; Attinger-Toller A; Toggweiler S; Kobza R; Moccetti F; Cuculi F; Jolly SS; Bossard M
    J Am Heart Assoc; 2021 Aug; 10(16):e021198. PubMed ID: 34369166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of resveratrol on C-reactive protein: An updated meta-analysis of randomized controlled trials.
    Gorabi AM; Aslani S; Imani D; Razi B; Sathyapalan T; Sahebkar A
    Phytother Res; 2021 Dec; 35(12):6754-6767. PubMed ID: 34472150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ginger (Zingiber officinale) on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials.
    Morvaridzadeh M; Fazelian S; Agah S; Khazdouz M; Rahimlou M; Agh F; Potter E; Heshmati S; Heshmati J
    Cytokine; 2020 Nov; 135():155224. PubMed ID: 32763761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of resistant starch type 2 on inflammatory mediators: A systematic review and meta-analysis of randomized controlled trials.
    Haghighatdoost F; Gholami A; Hariri M
    Complement Ther Med; 2021 Jan; 56():102597. PubMed ID: 33197672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease.
    Koc M; Karaarslan O; Abali G; Batur MK
    Tex Heart Inst J; 2010; 37(1):42-8. PubMed ID: 20200626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.